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Abstract 
Background   
Rapid effective triage is integral to emergency care in patients hospitalized for heart failure, to guide  the 
type and intensity of therapy. 
Several  indexes and scores have been proposed to predict outcome; most of the them are complex and unfit  
to use at the bedside. 
 
Methods 
We propose a new prognostic index for in hospital mortality in acute heart failure.  
The index was built according to the formula;  220 – age – heart rate + systolic blood pressure – ( creatinine 
X 10). The index was tested in 1628 patients admitted for acute heart failure and enrolled, from November 
2007 to  December 2009, in the Italian  Registry on Heart Failure Outcome ( IN-HF);  a prospective, 
multicentre, observational study. 
 
Results  
The prognostic index was an independent  predictor for in hospital mortality risk ( c statistic= 0.74)  
(p<0.0001), together with left ventricular ejection fraction (p= 0.001), Glycemia ( p= 0.019) and hemoglobin 
concentration (p = 0.002).  
 
Conclusion 
A simple prognostic index based on variables easily assessed can be useful to predict mortality in acute heart 
failure at the first arrival in hospital.   
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Introduction 
Heart Failure (HF) is one of the prevalent and increasingly  common reason for hospitalization in the west 
countries and this multifactorial  condition  has a substantial public health and economic impact.   
Actually a wide range of  therapies exists and the possibility to predict  the outcome could guide appropriate 
applications.  
Several prediction models have been proposed (1)(2) (3)(4) in patients admitted for HF.  
These models are not widely used in clinical practice, despite their validation in several studies. 
The reason could be the number of the variables involved and the complexity of the algorithms for obtaining 
a synthetic risk value.  
The objective of this study is to propose a new, user friendly and  accessible Prognostic Index (PI) 
to predict in-hospital mortality for Acute Heart Failure (AHF). 
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The PI was tested using  the database of the Italian Registry on Heart Failure Outcome from patients with 
Acute Heart Failure  hospitalized on 61 Italian  Cardiology Centres (5). 
 
Methodogy 
 
The Italian Registry on Heart Failure Outcome ( IN-HF) is a national, prospective, multicentre, observational 
study.  
The goal of the study was to improve knowledge of demographic, clinical and  biological characteristics, to 
assess the diagnostic and therapeutic approach, the outcome and the prognostic predictors in patients with 
HF, in the “ real word ”.  
Patients were enrolled in the study from November 2007 to  December 2009 and followed for 1 year.  
Exclusion criteria were age below 18 years and a patient’s unwillingness to participate. 
The participating centres were a mix of academic and community hospitals, well distributed over the whole 
country.  
All variables were collected at admission in cardiology centres and registered in a central database using a 
web connection.  
A total number of 5610 patients were included in the original study.   
We considered, for our analysis, only subjects classified as Acute Heart Failure (1855 patients), new HF  
( 797 pts.) (43%) or worsening HF ( 1058 pts.) (57%). 
From the total cohort of 1855 patients,  227(13%) were excluded, lacking of the all considered variables. 
AHF was defined according to the European Society of Cardiology (ESC) Guidelines during the enrolment 
period (6).  
A total number of 1628 patients (87%) were submitted to our  analysis.  
General characteristics of the study population and the considered variables are shown in Table 1. 
The mean age was 72.4±11.6 (range 21-98) years.  
Women were  650 ( 40%)  of the cohort. 
An Implantable Cardioverter Defibrillator (ICD)  and/or a Cardiac Resynchronization Therapy (CRT) were 
present  in 203 subjects (12.4%);  168 patients (10.3%) had an implanted Pacemaker; thus a number of  371 
pts (22.8%) had  an electrical device and possibly a paced rhythm. 
The Atrial Fibrillation documented by ECG at admission or anamnestic was present in 44.5% of the patients.   
Diabetes was present in  41.2% of pts, Previous Acute Myocardial Infarction (AMI) in 34.6%, Chronic 
Obstructive Pulmonary Disease (COPD) in 31.8%, 25.4% has had a  previous myocardial revascularization 
therapy, 1073  (65%) had a story of  hypertension. 
The mean value of the LVEF was  37.7±13.9 %.  
The pharmacological therapeutic interventions during the acute phase were with Furosimide in 99,4%, other 
intra venous Diuretics 15.7%, i.v. Nitrates 29.9%,  Dopamine 13.9%, Dobutamine 7.7%, Levosimendan 
3.9%.  
The  variables collected and considered possible predictors of in-hospital mortality have been divided in our 
as  in the original study(5) in; demographic (age and sex); anamnestic  (history  of atrial fibrillation, chronic 
obstructive pulmonary disease, diabetes, peripheral vascular disease, previous myocardial infarction,  
previous stroke or TIA, previous and treated hypertension, Implantable Pace Maker, Implantable 
Cardioverter Defibrillator, Cardiac Resynchronization Therapy) ; laboratory (serum sodium, serum 
hemoglobin, glycemia, serum creatinine); clinical  ( systolic blood pressure, diastolic blood pressure, heart 
rate, PI ) and  instrumental by 2D-echo (left ventricular ejection  fraction ). 
The PI was built considering the predictors for mortality evaluated in our previous studies (7) (8), in large 
studies (9) (10) (11) and  in IN-HF and according to the  formula;  
220- age – heart rate + systolic blood pressure – (creatinine X 10). 
The PI  was calculated in all patients (1628) and the statistical power was evaluated in predicting  
 
 
3 
 
hospital mortality for any cause. 
 
 Statistical methods 
 
In the preliminary univariate analysis, means ± SD and percentage frequencies were used as descriptive 
summaries, respectively, for the continuous and categorical variables. Group differences were assessed with 
the unpaired Student’s t-test for continuous variables and with X² or Fisher’s exact test for categorical 
variables and the corresponding results were employed as a preparatory tool to explore the association with 
the event from a more accurate multivariate perspective. 
The multivariate analysis was based on the logistic regression model, in order to identify independent 
predictors and to estimate the adjusted effect of the PI on the binary outcome of interest. 
Subsequently, the ROC curve of the PI was built and the optimal cut-off value was determined with the 
resulting accuracy measures (sensitivity and specificity) and predictive values. 
All tests performed in the analysis were two-sided and a p-value < 0.05 was considered statistically 
significant.  
Analyses were performed with SAS system software. 
 
Results. 
 
The in-hospital death rate, for any cause, was 5.7% ( 92 deaths), almost 90% of deaths were cardiac.  
In Table 2 is reported the univariate analysis of the all variables. 
As shown, none of the categorical variables was statistically significant.  
At the contrary all the continuous variables, except the BMI ( p = 0.95) and Heart Rate ( p= 0.45), were 
significant. 
The Results of the logistic regression model are shown in Table 3. 
The independent variables were; LVEF,  p = 0.001, OR 0.96,  95% CI ( 0.94 - 0.98 );  
Glycemia, p = 0.019, OR 1.003,  95% (1.00-1.005); Hb, p = 0.002, OR 0.84, 95% (CI 0.75-0.93);  
PI,  p = < 0.0001, OR 0.98,  95% CI 0.97-0.99. 
ROC curve  (Fig 1) of PI showed  the best AUC value  0.74 with a  sensitivity 72.8% and specificity 62.3%.  
The PI  Positive Predictive Value (PPV) was  10.4%, Negative Predictive Value (NPV) was 97.5%. 
 
Discussion 
 
Our analysis was made on the basis of a Registry which recruited patients admitted consecutively in hospital 
for acute and chronic heart failure. 
The choice of a registry was done to adhere to a real representative patients spectrum. 
Analysis of the Italian Registry was conducted to test a new, practical, friendly user risk-prediction tool that 
could be proposed for larger disposable databases and in clinical practice.  
The majority of the studies that obtained mortality risk predictors have considered single variables, but in the 
same patient  multiple risk factors contemporary exist, thus the analysis should consider the combination and 
interaction of these factors. 
This goal is respected in our analysis  and  PI is a combination-interaction of predictors.  
Usually the proposed clinical models to stratify the risk in pathological conditions are scores that put patients 
into a category risk and not in an individual position. 
Moreover, significant disadvantages of the risk schemes are the complexity of calculations and  the need  to 
convert  point scores in nomograms.  
The simplicity and the parsimony of the variables of the PI makes it fit to evaluate a patient rapidly and at 
bedside. 
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Our PI evaluates patient’s risk, it does not require to convert  the value  in nomograms. 
Considering the  four variables  in the formula, age, heart rate, systolic blood pressure, and creatinine 
concentrations, we can say that these variables have been found  independent  predictors for mortality  in 
most of the large studies concerning  HF (9) (10) (11) (12).   
Moreover, PI  is not an artificial tool, because the formula has a precise biological and physiological 
meaning. 
In fact, there is no doubt that age is a powerful risk factor for mortality.   
“ Senectus ipsa est morbus ”, as Terentius said (13). 
Subtracting the  numbers of the years to 220, we obtain the theoretical maximal frequency, it means the 
maximal O² consumption for that patient; in other words the maximal aerobic power.  
Considering the formula, it is evident that increasing  heart rate decreases the interval to the anaerobic 
threshold.  
Heart Rate (HR), the second variable of PI is a well known independent predictor of cardiovascular death, 
particularly in ischemic heart disease. 
Elevated HR may be a marker of haemodynamic instability and/or may represent an unfavourable increase of 
the sympathetic activity.  
An elevation on HR  increases the myocardial oxygen consumption and, at the same time, reduces the 
availability of the diastolic time for coronary flow.  
In fact the shortening of the cardiac cycle reduces the duration of the single intervals. 
Despite these considerations HR in the Italian Registry analysis is the only variable of the formula which did 
not show to be an independent predictor for death.  
The reason is in the fact that a lot of patients (22.8%)  enrolled in the Registry  had an implanted Pacemaker 
(10.3%) or ICD-CRT ( 12.5%) and 44.5% had an atrial fibrillation at admission or anamnestic; nevertheless 
we have maintained HR in the formula, thinking  it adds something to PI value. 
Systolic blood pressure is a predictor of mortality for its low values. 
Low systolic blood pressure, in fact, should be regarded with suspicion in HF (14), as a  marker of a poor 
stroke volume and cardiac function  reflecting inadequate response to stress.  
Additional lowering of the systolic pressure in patients with baseline hypotension may result in organ 
hypoperfusion, causing  worsening renal function, cardiac ischemia and reducing cardiac out-put. 
According to our study, the well known sentence; “ the lower the better ”, for blood pressure (15), true in 
primary prevention could be wrong in secondary prevention, particularly in patients with HF. 
In the OPTIMAZE-HF (11) a large registry for patients hospitalized with HF in 259 United States hospitals 
(48612 patients enrolled) , admission low systolic blood pressure was found to be one of the most strongly 
predictive variables for in-hospital mortality, whereas the increased SBP up to the threshold of 
approximately 160 mm Hg was associated  with a lower risk (16). 
Why do subjects admitted for heart failure with low systolic pressure are at higher risk of death? 
Low systolic blood pressure can be a consequence of left ventricular  dysfunction, frequently associated with  
right ventricular involvement; moreover, low systolic pressure can be expression of a damaged 
neurohormonal pathway, resulting in an unfit  response to usual and unusual stressors (17).  
The second question is; which is the meaning of an important systolic reduction by drugs as ACE inhibitors, 
angiotensin receptors blocker and  β -blockers  in HF.  
These drugs should increase stroke volume reducing heart rate and the peripheral resistances; thus a 
reduction of systolic pressure can indicate that  lower peripheral resistances and lower heart rate are not 
followed by an increasing  stroke volume, unmasking a severe systolic dysfunction.  
“ Last but not least”  in the formula is the creatinine blood concentration.  
Creatinine is considered to provide only a rough estimate of the renal function,  despite the glomerular 
filtration rate (GFR) which is regarded as the best clinical index  of the kidney function. 
In our formula we maintained, as a variable, the creatinine concentration, because the formulas calculating  
GFR contains the patient’s age which is just considered in our model, independently. 
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Several studies have demonstrated that low kidney function is a significant risk factor for mortality in HF.  
The ADHERE Registry (10) studied hospitalized  patients with a primary diagnosis of Acure 
Decompensated Heart Failure and  revealed that blood urea nitrogen (BUN) level of 43 mg/dl or higher  was 
the best single predictor of mortality.  
The second best predictor was admission systolic blood pressure (SBP) < 115 mm Hg.  
Serum creatinine levels of 2.75 mg/dl or higher provided additional prognostic value  in patients with BUN 
level ≥ 43 mg/dl and SBP ≤  115 mm Hg.  
The authors employed a Classification and Regression Tree  method (CART) to derive the risk of mortality, 
identifying  acutely decompensated heart failure patients at several levels of risk in the validation cohort. 
Heart rate and age did not improve the risk stratification  and this surprising result, especially for age, can be 
due to the CART method  and to the very strong power  of the predictors. 
These  findings underscore the importance of the renal function in HF, confirming the established link 
between  heart and kidney and thus the association between clinical outcomes and markers of renal function 
(18) (19) (20).  
How does the kidney insufficiency  work, in worsening heart failure?  
First of all, kidney impairment causes sodium and fluid retention, determining a ventricular overload thus a 
progressive ventricular dilation and  remodeling.  
Furthermore, renal insufficiency is associated  with multiple changes in vascular biology, including 
abnormalities in coagulation/fibrinolytic system, endothelial dysfunction,  insulin resistance,  hyperactivation 
of the sympathetic nervous  and rennin-angiotensin systems; all of them associated with adverse outcome 
(21).  
Thus the synergistic action increases the predictive power of the single variables, in a multiplicative manner. 
Finally some considerations about the predictive values of PI.  
The low positive predictive value (10.4) can depend on the low percentage of  in-hospital mortality (5.7% ); 
at the contrary PI has a very high negative predictive value,  97.5%. 
This high negative predictive value  can be a good tool for beginning the screening of the subjects admitted 
in hospital for acute HF, meaning that subjects who have a PI higher than 168  have a low risk (only a 2.5 % 
in our study) to die. 
 
The study limitations 
 
The first  limitation of the study is the small size of the cohort .  
The second  is that PI  has been tested in a retrospective way, in a derivation test.  
A desirable validation  should  be obtained in  larger populations and in a prospective way.  
The third consideration to do is that the four variables in the formula are equally weighted, all as 1, but it is  
probably that it’s not true in the real world; in fact it is possible that age or creatinine concentrations can 
have a stronger impact in  outcome  than systolic pressure and heart rate.  
Validation with prospective studies should be done to confirm the efficiency of  this simple formula that is 
based on physiological considerations.    
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Table 1. General characteristics of study population: percentage frequency (%) for categorical 
variables, mean and standard deviation (Sd) for continuous variables. 
 
Categorical 
variables 
% Continuous 
variables 
Mean±Sd 
With events 5.7 Age (years) 72.4 ± 11.6 
Males 60.0 BMI (kg/m2) 27.7 ± 5.1 
Diabetes 41.2 DBP (mmHg) 78.8 ± 17.5 
Previous 
Hypertension 
65.9 SBP (mmHg) 135.6 ± 32.5 
Treated Hypertension 60.8 Heart Rate (bpm) 93.1 ± 25.4 
Previous AMI 34.6 LVEF (%)  37.7 ± 13.9 
Previous 
Revascularization 
25.2 Creatinine (mg/dl) 1.4 ± 1.0 
PVD 19.7 Glycemia (mg/dl) 162.5 ± 79.7 
COPD 31.8 Hb (g/dl) 12.6 ± 2.1 
Previous Ictus-TIA 8.6 Sodium (mEq/L) 138.9 ± 4.7 
ICD-CRT 12.5 PI 175.9 ± 40.6 
PCMK 10.3   
AF ECG-Previous AF 44.5   
AF, Atrial Fibrillation, AMI, Acute Myocardial Infarction; BMI, Body Mass Index; COPD, Chronic 
Obstructive Pulmonary Disease; CRT, Cardiac Resynchronization Therapy; DBP, Diastolic Blood 
Pressure; Hb, Haemoglobin; ICD, Implantable Cardioverter Defibrillator; LVEF, Left Ventricular 
Ejection Fraction; PCMK, Pacemaker; PVD, Peripheral Vascular Disease; PI, Prognostic Index; 
SBP, Systolic Blood Pressure; TIA, Transient Ischaemic Attack. 
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Table 2. Univariate analysis by outcome status: percentage frequency for categorical variables 
(upper panel), mean and standard deviation (Sd) for continuous variables (lower panel). 
 
Explanatory 
variables 
Without 
events 
With 
events 
p-value 
Males 60.3 55.4 0.356 
Diabetes 41.0 45.7 0.374 
Previous Hypertension 66.0 64.1 0.711 
Treated Hypertension 61.2 53.3 0.130 
Previous AMI 34.6 33.7 0.854 
Previous 
Revascularization 
25.3 23.9 0.772 
PVD 19.7 19.6 0.982 
COPD 31.5 37.0 0.270 
Previous Ictus-TIA 8.3 13.0 0.118 
ICD-CRT 12.4 14.1 0.620 
PCMK 10.4 8.7 0.598 
AF ECG-Previous AF  45.3 40.6 0.385 
Age (years) 72.0 ± 11.5 78.3 ± 10.9 <0.0001 
BMI (kg/m2) 27.7 ± 5.2 27.6 ± 4.4 0.955 
DBP (mmHg) 79.5 ± 17.2 67.5 ± 19.7 <0.0001 
SBP (mmHg) 136.9 ± 32.2 114.5 ± 30.9 <0.0001 
Heart Rate (bpm) 93.0 ± 25.4 94.7 ± 26.3 0.459 
LVEF (%) 38.1 ± 13.9 31.5 ± 11.2 <0.0001 
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Creatinine (mg/dl) 1.4 ± 0.9 2.1 ± 1.5 <0.0001 
Glycemia (mg/dl) 161.3 ± 79.1 182.3 ± 85.7 0.005 
Hb (g/dl) 12.6 ± 2.1 11.7 ± 2.1 <0.0001 
Sodium (mEq/L) 139.0 ± 4.6 137.0 ± 6.4 0.003 
PI 178.0 ± 39.6 141.0 ± 42.1 <0.0001 
AF, Atrial Fibrillation, AMI, Acute Myocardial Infarction; BMI, Body Mass Index; COPD, Chronic 
Obstructive Pulmonary Disease; CRT, Cardiac Resynchronization Therapy; DBP, Diastolic Blood 
Pressure; Hb, Haemoglobin; ICD, Implantable Cardioverter Defibrillator; LVEF, Left Ventricular 
Ejection Fraction; PCMK, Pacemaker; PVD, Peripheral Vascular Disease; PI, Prognostic Index; 
SBP, Systolic Blood Pressure; TIA, Transient Ischaemic Attack. 
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 Table 3.  Results of the logistic regression model. 
 
Explanatory 
variables 
OR 95% CI p-value 
DBP  0.984 0.967 - 1.001 0.063 
LVEF 0.968 0.949 - 0.987 0.001 
Glycemia 1.003 1.000 - 1.005 0.019 
Hb 0.840 0.752 - 0.939 0.002 
Sodium 0.971 0.932 - 1.011 0.157 
PI 0.985 0.978 - 0.991 <0.0001 
OR, Odds Ratio; CI, Confidence Interval. 
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Prognostic Index.  ROC Curve. 
 
PI= Prognostic Index 
AUC= Area Under Curve 
Sens= Sensitivity 
Spec= Specificity 
PV+= Positive Predictive Value 
PV- = Negative Predictive Value 
. 
 
